Endometrial Sampling Technologies for the Office Or Clinic Forrest C

Total Page:16

File Type:pdf, Size:1020Kb

Endometrial Sampling Technologies for the Office Or Clinic Forrest C esources Rfor Women’s Health Volume 1, Number 1, October 1997 Endometrial Sampling Technologies for the Office or Clinic Forrest C. Greenslade, Ph.D.; José David Ortiz Mariscal, M.D.; Marian Abernathy, MPH he health care gy for resolving some by a non-physician for most women. By con- provider working in pathologies or circumstances provider), increases accessi- trast, D&C requires an oper- T private practice has related to a woman’s health bility as well as acceptability ating room which increases a wide range of health care that can arise at different technologies from which to times during her life. Table 1: Comparison of Vacuum choose in diagnosing and Aspiration and Sharp Curettage (D&C) managing obstetrical and Endometrial sampling can for Endometrial Sampling gynecological problems. be performed to determine Access to a variety of tech- the potential causes of infer- Vacuum Aspiration Sharp Curettage nologies has the potential to tility, to evaluate abnormal help health care providers uterine bleeding, to diagnose Uses flexible plastic or Requires a sharp curette offer better, more appropri- endometrial cancer or hyper- metal cannulae ate reproductive health care; plasia, and to monitor the effects of hormone replace- Does not require cervical Mechanical dilation often however, it can also lead to performed the overuse of some costly ment therapy. dilation technologies, such as ultra- Anesthesia or analgesia Paracervical anesthesia or sound, that may only be Vacuum aspiration is a sim- optional, depending on parenteral analgesic often available from specialists or ple, safe technology that can patient’s need administered in hospital settings. Other be used for endometrial sam- technologies provide innov- pling, and that, in many More convenient for — ative applications that can cases, can be used as an patient and provider be utilized in a wide range of alternative to sharp curet- settings. For example there tage or dilation and curet- Lower rate of complications — tage (D&C), a surgical pro- (uterine hemorrhage, are many occasions when infection and perforation) endometrial biopsy is appro- cedure that requires facilities with operating rooms (Table priate or requested for either Approximately 1/10 the cost — diagnostic or sampling pur- 1). Using vacuum aspiration of D&C per procedure poses. An endometrial sam- as an alternative to D&C pling technique using vacu- offers advantages for both Specimens consist of strips Specimens fragmented um aspiration can be per- the patient and provider. A of tissue with little blood and mixed with blood formed in an office or simple vacuum aspiration proce- clinic setting. This publica- dure, performed as an ambu- Office or outpatient Usually needs operating procedure room tion focuses on endometrial latory procedure in an office sampling: a useful technolo- or primary clinic (potentially Ipas Resources for Women’s Health 1 the cost of care; furthermore, um aspirator. By the early Suarez et al., 1983; Marik used to monitor the effect of the woman usually receives 90s, vacuum aspiration had and Tatarun, 1984; Hulka, hormone replacement thera- general anesthesia, increas- become the standard tech- 1988), so that Asherman’s py (Kaunitz, 1995). ing both her risk and recov- nology for endometrial biop- syndrome (associated with ery time. sy in the United States intrauterine adhesions and Vacuum Sources although sharp curettage is traumatic amenorrhea) may Endometrial sampling Technologies still used (Hulka, 1991). be less likely following vacu- devices achieve suction in Report um aspiration (Grimes, one of three ways: a vacuum Endometrial sampling Safety 1982). syringe, an internal piston, devices employing vacuum The safety advantage of vac- or a vacuum pump (Table aspiration provide in-office, uum aspiration over sharp Effectiveness 2). The Ipas MVA syringe diagnostic and monitoring curettage is supported by Histologic analyses of features a locking valve services minimizing the need research on vacuum aspira- endometrial tissue provide which allows the provider to for procedures requiring tion for a variety of indica- health care providers with establish a vacuum before D&C. tions. This body of research important information con- beginning the aspiration spans 30 years, encompasses cerning adenocarcinoma, procedure. Internal piston The use of vacuum aspira- over 80 studies, and involves atypical hyperplasia, polyps, devices generate suction that tion for endometrial biopsy more than 500,000 patients submucosal myomas, chron- draws a column of tissue into has been well established (Greenslade et al., 1993). ic inflammation, and proges- the tube when the piston is since Grimes’ 1982 analysis Vacuum aspiration removes tational effect in anovulatory withdrawn. Both mecha- of 13,598 sharp curettage less of the basal layer of the cycles (Baughan, 1993). nisms may be manual or procedures and 5,851 proce- endometrium than sharp Aspiration endometrial sam- electrical and are reusable. dures using the Vabra vacu- curettage (Hale et al., 1976; pling devices can also be Table 2: Endometrial Sampling Devices for the Office or Clinic Vacuum Source Locking-valve Syringe Internal Piston Electric or Mechanical Pump Characteristics Flexible cannulae, reusable Entire device is disposable Cannulae and collection of Use or disposable; reusable chamber disposable syringe Sampling Plastic (2-7mm) Cannulae Plastic (2-3mm) Plastic or stainless steel (2-7mm) (external diameter) 60 cc syringe collects large, Slim flexible device Sample chamber collects Endometrial diagnostically adequate sam- collects small but specimen; compares favor- Samples ple with a high ratio of diagnostically ably with those obtained by endometrial tissue to blood adequate sample diagnostic D&C clot. Ipas Gynecologic Aspiration Examples Pipelle, Z-Sampler, Tis-U-Trap, Vabra Aspirator, Kits with Cannulae & Syringe Gynosampler, Pipet Masterson Endometrial Biopsy System Curette 2 Resources for Women’s Health Ipas Cannula better quality than sharp cancer (Suarez et al., 1983) Endometrial samples Ipas 4mm flexible plastic curettage samples, as there and, when performed with obtained with MVA are par- cannulae for endometrial were larger strips of tissue hysteroscopy, superior to ticularly valuable for biopsy have two whistlecut and a higher ratio of tissue sharp curettage (Goldrath research because large sam- apertures near the distal end. to blood clot in the speci- and Sherman, 1985; Suarez ples can be obtained to pre- Novak’s 2-4mm cannulae men, facilitating pathologic et al., 1983). pare endometrial cells for tis- and Randall’s 4mm cannula diagnosis (Hale et al., 1976; sue cultures. Examination of for endometrial biopsy are Suarez et al., 1983). Mateo Sanez et al. found cell cultures derived from reusable and made of stain- 92.2% of samples obtained such samples yields valuable less steel. These cannulae Furthermore, MVA was with MVA were adequate, as insights into various aspects attach to the syringe via found to be as good a diag- compared with 84.4% of of reproductive physiology, Luer-Loks. Internal piston nostic tool as sharp curettage samples obtained with including certain types of devices are plastic and usual- in detecting endometrial Novak’s cannula. infertility. ly 3mm in external diameter. Pump vacuum sources use stainless steel or plastic can- nulae ranging from 2-7mm What is MVA? in diameter. MVA is a simple yet effective vacuum aspiration technique. This innovative technology consists of a flexible plastic cannula that is connected to a Endometrial manual aspiration syringe with a locking valve to perform an endometrial Sampling biopsy or a uterine evacuation. MVA is a very effective method and safer with Ipas MVA than sharp curettage. With the MVA instruments, a qualified health care Instruments provider may perform a wide range of ambulatory surgical procedures A number of studies evaluat- using the capabilities already available in the office or treatment room. ing endometrial biopsy per- Thus, the patient is not forced to be admitted to a hospital and instead can formed with MVA demon- undergo a safe and effective procedure in a private setting. strate it to be an effective and safe technology for col- lecting endometrial samples MVA Instruments Characteristics (Hale et al., 1976; Ladipo, ◆ Manufactured with high quality standards. 1976; Suarez et al., 1983; Goldrath and Sherman, ◆ Easy to learn: Each instrument kit contains detailed and illustrated 1985; Mateo Sanez et al., instructions to facilitate learning the operative technique. 1994). ◆ High level of effectiveness, safety and patient acceptability. Tissue samples collected with MVA were consistently ◆ Of practical use in the medical office, clinic and hospital. adequate for histologic diag- nosis (Hale et al., 1976; ◆ May be used with local anesthesia (paracervical block) so that the Ladipo, 1976; Mateo Sanez patient avoids the risk of epidural or general anesthesia. et al., 1994). Hale found MVA superior to sharp ◆ Of great application in ambulatory surgery. curettage in sampling the cornual regions of the uterus. ◆ Portable, not electric. In Suarez’ study, 82% of MVA samples were adequate for diagnosis compared to Combining all these characteristics, MVA yields a significant benefit for both 76% of those obtained with the provider and the patient. sharp curettage. MVA sam- ples were judged to be of Ipas Resources for Women’s Health 3 Use of MVA for endometrial Contraindications biopsy requires little if any and Precautions What are the pain control medication.
Recommended publications
  • Hysteroscopy with Dilation and Curretage (D & C)
    501 19th Street, Trustees Tower FORT SANDERS WOMEN’S SPECIALISTS 1924 Pinnacle Point Way Suite 401, Knoxville Tn 37916 P# 865-331-1122 F# 865-331-1976 Suite 200, Knoxville Tn 37922 Dr. Curtis Elam, M.D., FACOG, AIMIS, Dr. David Owen, M.D., FACOG, Dr. Brooke Foulk, M.D., FACOG Dr. Dean Turner M.D., FACOG, ASCCP, Dr. F. Robert McKeown III, M.D., FACOG, AIMIS, Dr. Steven Pierce M.D., Dr. G. Walton Smith, M.D., FACOG, Dr. Susan Robertson, M.D., FACOG HYSTEROSCOPY WITH DILATION AND CURRETAGE (D & C) Please read and sign the following consent form when you feel that you completely understand the surgical procedure that is to be performed and after you have asked all of your questions. If you have any further questions or concerns, please contact our office prior to your procedure so that we may clarify any pertinent issues. Definition: HysterosCopy is an outpatient procedure that allows your doctor direct visualization of the inside of the uterine cavity (womb) by inserting a thin lighted telescope (hysteroscope) through the vagina (birth canal) and cervix, without making an abdominal incision. This procedure enables your doctor to examine the lining of the uterus, look for polyps, fibroids, scar tissue, blockages of the fallopian tubes, and abnormal partitions. In addition, this procedure allows your doctor to remove or surgically treat many of the abnormalities seen. Dilation and Curettage (D&C) allows your doctor to take a sample of the tissue that lines your uterus (endometrium) and/or to remove polyps, fibroid tumors, or hyperplasia. Suction D&C is used in cases of miscarriage.
    [Show full text]
  • 2021 – the Following CPT Codes Are Approved for Billing Through Women’S Way
    WHAT’S COVERED – 2021 Women’s Way CPT Code Medicare Part B Rate List Effective January 1, 2021 For questions, call the Women’s Way State Office 800-280-5512 or 701-328-2389 • CPT codes that are specifically not covered are 77061, 77062 and 87623 • Reimbursement for treatment services is not allowed. (See note on page 8). • CPT code 99201 has been removed from What’s Covered List • New CPT codes are in bold font. 2021 – The following CPT codes are approved for billing through Women’s Way. Description of Services CPT $ Rate Office Visits New patient; medically appropriate history/exam; straightforward decision making; 15-29 minutes 99202 72.19 New patient; medically appropriate history/exam; low level decision making; 30-44 minutes 99203 110.77 New patient; medically appropriate history/exam; moderate level decision making; 45-59 minutes 99204 165.36 New patient; medically appropriate history/exam; high level decision making; 60-74 minutes. 99205 218.21 Established patient; evaluation and management, may not require presence of physician; 99211 22.83 presenting problems are minimal Established patient; medically appropriate history/exam, straightforward decision making; 10-19 99212 55.88 minutes Established patient; medically appropriate history/exam, low level decision making; 20-29 minutes 99213 90.48 Established patient; medically appropriate history/exam, moderate level decision making; 30-39 99214 128.42 minutes Established patient; comprehensive history exam, high complex decision making; 40-54 minutes 99215 128.42 Initial comprehensive
    [Show full text]
  • Endometrial Biopsy | Memorial Sloan Kettering Cancer Center
    PATIENT & CAREGIVER EDUCATION Endometrial Biopsy This information describes what to expect during and after your endometrial biopsy. About Your Endometrial Biopsy During your endometrial biopsy, your doctor will remove a small piece of tissue from the lining of your uterus. The lining of your uterus is called your endometrium. This tissue is sent to the pathology department to be examined under a microscope. The pathologist will look for abnormal cells or signs of cancer. Before Your Procedure Tell your doctor or nurse if: You’re allergic to iodine. You’re allergic to latex. There’s a chance that you’re pregnant. If you still get your period and are between ages 11 and 50, you will need to take a urine pregnancy test to make sure you’re not pregnant. You won’t need to do anything to get ready for this procedure. During Your Procedure You will have your endometrial biopsy done in an exam room. You will lie on your back as you would for a routine pelvic exam. You will be awake during the procedure. Endometrial Biopsy 1/3 First, your doctor will put a speculum into your vagina. A speculum is a tool that will gently spread apart your vaginal walls, so your doctor can see your cervix (the bottom part of your uterus). Next, your doctor will clean your cervix with a cool, brown solution of povidone- iodine (Betadine® ). Then, they will put a thin, flexible tool, called a pipelle, through your cervix and into your uterus to take a small amount of tissue from your endometrium.
    [Show full text]
  • Hysteroscopy an Internal Examination of Your Womb
    We Care Doncaster and Bassetlaw Teaching Hospitals NHS Foundation Trust an internal examination Hysteroscopy of your womb This information leaflet has been given to you to help answer some of the questions you may have about having a hysteroscopy. It explains the benefits, risks and alternatives of the procedure as well as what you can expect when you come to hospital. If you have any questions or concerns, please do not hesitate to speak with your doctor or nurse. What is a hysteroscopy? A hysteroscopy is a procedure which uses a fine telescope, called a hysteroscope, to examine the lining and shape of the uterus (womb cavity). It is performed either in the outpatient department or in theatre, usually as a day patient. The Consultant will discuss with you where it is best for you to have the procedure. What are the benefits of having a hysteroscopy? A hysteroscopy can help to find the cause of problems relating to: • Heavy vaginal bleeding • Irregular periods • Bleeding between periods • Bleeding after sexual intercourse • Bleeding after menopause • Persistent discharge. In some cases, once a diagnosis has been made, the hysteroscope can also be used in the treatment of the problem. We Care WPR8773 Apr 2018 Review date by: Apr 2020 For example, problems that can be treated during a hysteroscopy are: • fibroids (growths in the uterus which are not cancer) • polyps (blood-filled growths which are not cancer) • thickening of the lining of the uterus (the endometrium) • removal of displaced intrauterine contraceptive devices removal of scar tissue. What are the risks associated with a hysteroscopy? Your Consultant/Doctor will explain these risks to you before you sign or give a verbal consent for the procedure.
    [Show full text]
  • Risks of Hysteroscopy and Fractional Dilation and Curettage South Care Women's Florida
    Risks of Hysteroscopy and Fractional Dilation and Curettage South Florida Women's Care The Procedure I will be undergoing is ______________________________________________________ _________________________________________________________________________________________. 1. Damage to uterus, bowel, bladder, urinary organs: Perforation of the uterus is a small risk. If that were to occur, laparoscopy (placing a camera in the umbilicus) may need to be done to make sure the uterus wasn’t bleeding and repair any damage. Cervical stenosis (inability of the cervix to dilate) can increase the rise of uterine perforation. 2. Fluid overload: Special attention is taken to monitor exactly how much fluid goes into your uterus during the hysteroscopy. Rarely, extra fluid can accumulate in your lungs, called pulmonary edema. 3. Damage to nerves, skin: We are very careful to position your legs very gently before surgery. Rarely, the nerves in your legs can “go to sleep” during surgery and can have temporary nerve damage. 4. Infection: You are given an antibiotic during surgery to decrease any risk of infection. Rarely, infection can occur after surgery and need medicine, and even surgery to correct. 5. Need for further surgery: If your procedure involves treatment for heavy bleeding (i.e. Removing a polyp or endometrial ablation), it is possible that these procedures will not cure your underlying problem and further surgery will be needed. 6. Risks for endometrial ablation: Sometimes your cervix will not close over the device and cause the procedure to be abandoned for safety reasons. There is also risk of damage to abdominal organs. About 5-10% of ablations done need further surgery (hysterectomy) to stop heavy bleeding.
    [Show full text]
  • Dilation and Curettage (D&C)
    Fact Sheet From ReproductiveFacts.org The Patient Education Website of the American Society for Reproductive Medicine Dilation and Curettage (D&C) This fact sheet was developed in collaboration with The Society of Reproductive Surgeons “Dilation and curettage” (D&C) is a short surgical as intestines, bladder, or blood vessels, are injured. If procedure that removes tissue from your uterus (womb). any of these organs are injured, they must be repaired You may need this procedure if you have unexplained with surgery. However, if no other organs have been or abnormal bleeding, or if you have delivered a baby injured, long-term complications from a perforation are and placental tissue remains in your womb. D&C also is extremely rare and the uterus heals on its own. performed to remove pregnancy tissue remaining from can occur after a D&C. If you are not a miscarriage or an abortion. Infections pregnant at the time of your D&C, this complication How is the procedure done? is extremely rare. However, 10% of women who were D&C can be done in a doctor’s office or in the hospital. pregnant before their D&C can get an infection, usually You may be given medications to relax you or to put you within 1 week of the procedure. It may be related to a to sleep for a short time. Your doctor will slowly widen sexually transmitted infection or due to normal bacteria the opening to your uterus (cervix). Opening your cervix that pass from the vagina into the uterus during or can cause cramping.
    [Show full text]
  • The Role of Hysteroscopy in Diagnosing Endometrial Cancer
    The role of hysteroscopy in diagnosing endometrial cancer Certain hysteroscopic findings correlate with the likelihood of endometrial carcinoma—and the absence of pathology. Here is a breakdown of hysteroscopic morphologic findings and hysteroscopic-directed biopsy techniques. Amy L. Garcia, MD or more than 45 years, gynecologists He demonstrated the advantages of using have used hysteroscopy to diagnose hysteroscopy and directed biopsy in the eval- F endometrial carcinoma and to asso- uation of abnormal uterine bleeding (AUB) to ciate morphologic descriptive terms with obtain a more accurate diagnosis compared visual findings.1 Today, considerably more with dilation and curettage (D&C) alone clinical evidence supports visual pattern rec- (sensitivity, 98% vs 65%, respectively).2 ognition to assess the risk for and presence of Also derived from this work is the clini- IN THIS endometrial carcinoma, improving observer- cal application of the “negative hysteroscopic ARTICLE dependent biopsy of the most suspect lesions view” (NHV). Loffer used the following cri- (VIDEO 1). teria to define the NHV: good visualization Hysteroscopic In this article, I discuss the clinical evo- of the entire uterine cavity, no structural classification lution of hysteroscopic pattern recognition abnormalities of the cavity, and a uniformly of endometrial Ca of endometrial disease and review the visual thin, homogeneous-appearing endometrium findings that correlate with the likelihood of without variations in thickness (TABLE 1). The this page endometrial carcinoma. In addition, I have last criterion can be expected to occur only in provided 9 short videos that show hystero- the early proliferative phase or in postmeno- Negative scopic views of various endometrial patholo- pausal women.
    [Show full text]
  • A Critical Systematic Review and Meta-Analyses of Risk Factors for Fertility Problems in a Globalized World
    medRxiv preprint doi: https://doi.org/10.1101/2021.05.06.21256676; this version posted May 8, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license . Looking beyond the obvious: a critical systematic review and meta-analyses of risk factors for fertility problems in a globalized world Authors: R.R. Bayoumi1*, J. Boivin2*, H.M. Fatemi3, L. Hurt4, G.I. Serour5, S. van der Poel6 and C. Venetis7. 1* Corresponding author: PhD Student, School of Psychology, Cardiff University, Cardiff, Wales, UK; Takemi Fellow, Takemi Program in International Health, Harvard T.H. Chan School of Public Health, Boston, USA, [email protected] 2* Corresponding author: Professor of Psychology, School of Psychology, Cardiff University, Cardiff, Wales, UK, [email protected] 3: Professor of Obstetrics and Gynecology, Group Medical Director, ART Fertility Clinics, Abu Dhabi, UAE 4: Senior Lecturer, Division of Population Medicine, Cardiff University School of Medicine, Cardiff, Wales, UK 5: Professor of Obstetrics and Gynecology, Al Azhar University, Cairo, Egypt 6: Independent Consultant, Route de la Capite, Geneva, Switzerland 7: Associate Professor, Centre for Big Data Research in Health, University of New South Wales, Sydney, Australia Abstract Background: Well-established risk factors for fertility problems such as smoking have been included in fertility awareness efforts globally. However, these efforts neglect risks that women in low and middle-income countries (LMIC) face. Objective: To address this gap, we identified eight risk factors affecting women in LMIC and the aim of the current review was to estimate the impact of these risks on fertility.
    [Show full text]
  • Hysteroscopy Vs. Transvaginal Ultraultrasonography in the Diagnosis of Endometrial Lesions
    Caspian J Reprod Med, 2016, 2(1): 21-26 Caspian Journal of Reproductive Medicine Journal homepage: www.caspjrm.ir Original article Hysteroscopy vs. transvaginal ultraultrasonography in the diagnosis of endometrial lesions Zinatossadat Bouzari 1, Shahla Yazdani2, Sedigheh Esmailzadeh 2,*, Roza Shahhoseini3, Ali Fazli4, Mojgan Naeimi rad4 1Cellular & Molecular Biology Research Center, Department of Obstetrics & Gynecology, Babol University of Medical Sciences, Babol, Iran 2Infertility and Reproductive Health Research Center, Health Research Institute & Department of Obstetrics & Gynecology, Clinical Research Development Unit of Rouhani Hospital, Babol University of Medical Sciences, Babol, Iran 3Department of Obstetrics & Gynecology, Faculty of Medicine, Babol University of Medical Sciences, Babol, Iran 4Clinical Research Development Unit of Rouhani Hospital, Babol University of Medical Sciences, Babol-Iran Received: 11 Dec 2015 Accepted: 10 Mar 2016 Abstract Background: Abnormal uterine bleeding (AUB) is the most common gynecological problems that many factors are involved in its creation. Two common methods used to diagnose uterine lesions are vaginal ultraultrasonography and hysteroscopy. The aim of this study was to evaluate the diagnostic value of transvaginal ultraultrasonography and hysteroscopy in the diagnosis of intrauterine lesions leading to the AUB. Methods: A cross-sectional study was performed on 203 premenopausal post-menopausal women with complaints of abnormal uterine bleeding. A transvaginal ultraultrasonography was performed from the eligible subjects. In the second visit, a hysteroscopy was done and during the hysteroscopy procedure an endometrial biopsy was obtained from all the women. Pathology was considered as the gold standard and sensitivity, specificity, positive predictive value and negative predictive value were calculated for both methods using the Cat maker software.
    [Show full text]
  • Hysteroscopy Dilation and Curettage
    Hysteroscopy Dilation and Curettage Technique Procedure involves using a hysteroscope to place microinserts within the opening of the fallopian tubes from within the uterus. These inserts block the fallopian tubes for the purpose of permanent sterilization. Incisions No incisions are required for this procedure Operative Time Operative times vary greatly depending on the findings at the time of surgery. Your surgeon will proceed with safety as his/her first priority. Average times range from 15-30 minutes. Anesthesia • Local anesthesia or • Local anesthesia + IV sedation Preoperative Care • Schedule your case immediately after your period. • Your doctor will recommend that you take a hormonal medicine to thin the lining of your uterus prior to this procedure. • Nothing by mouth after midnight Hospital Stay • Office procedure • Day surgery Postoperative Care These guidelines are intended to give you a general idea of your postoperative course. Since every patient is unique and has a unique procedure, your recovery may differ. • Anti-inflammatory pain medicine, such as ibuprofen, naproxen, etc., is usually required for the first several days. Most patients do not need narcotics. • Driving is allowed once you have cleared anesthesia. • If they desire, patients may return to work on the day of the procedure. • You must use a form of reversible contraception until you undergo a hysterosalpingogram (HSG). This x-ray test will be performed 3 months after your procedure and will confirm that your fallopian tubes are occluded. 1700 6th Avenue South ● Birmingham, AL 35249 ● (205) 934-9999 .
    [Show full text]
  • STOP Performing Dilation and Curettage for the Evaluation Of
    STOP/START Diagnostic hysteroscopy spies polyp previously missed on transvaginal ultrasound and dilation and curettage. STOP performing dilation and curettage for the evaluation of abnormal uterine bleeding START performing in-office hysteroscopy to identify the etiology of abnormal uterine bleeding }expert commentary her treatment she had a 3-year history of Amy Garcia mD, Director, Center for abnormal vaginal bleeding. Results from con- Women’s Surgery and Garcia Institute for management secutive pelvic ultrasounds indicated that the Hysteroscopic Training, Albuquerque, and Clinical Assistant Professor, Department patient had progressively thickening endome- obg r of Obstetrics and Gynecology, University trium (from 1.4 cm to 2.5 cm to 4.7 cm). In-office O r f of New Mexico School of Medicine, Albu- E biopsy was negative for endometrial pathology. f querque. Dr. Garcia serves on the OBG ie An ultimate dilation and curettage (D&C) was K ManageMent Board of Editors. On the Web aig Dr. Garcia reports receiving grant support from Hologic; CASe In-office hysteroscopy spies being a consultant to Conceptus, Boston Scientific, Ethicon : Cr 12 intraoperative Endosurgery, IOGYN, Minerva, Hologic, Smith & Nephew, previously missed polyp ation videos from and Karl Storz Endoscopy; and being a member of the r A 51-year-old woman with a history of breast Dr. Garcia, at speakers’ bureau for Conceptus, Karl Storz Endoscopy, and ust ll obgmanagement.com cancer completed 5 years of tamoxifen. During Ethicon Endosurgery. I 44 OBG Management | June 2013 | Vol. 25 No. 6 obgmanagement.com performed with negative histologic diagnosis. FIGURE consecutive ultrasounds evaluating The patient is seen in consultation, and abnormal bleeding the ultrasound images are reviewed (FIGURE).
    [Show full text]
  • The Woman with Postmenopausal Bleeding
    THEME Gynaecological malignancies The woman with postmenopausal bleeding Alison H Brand MD, FRCS(C), FRANZCOG, CGO, BACKGROUND is a certified gynaecological Postmenopausal bleeding is a common complaint from women seen in general practice. oncologist, Westmead Hospital, New South Wales. OBJECTIVE [email protected]. This article outlines a general approach to such patients and discusses the diagnostic possibilities and their edu.au management. DISCUSSION The most common cause of postmenopausal bleeding is atrophic vaginitis or endometritis. However, as 10% of women with postmenopausal bleeding will be found to have endometrial cancer, all patients must be properly assessed to rule out the diagnosis of malignancy. Most women with endometrial cancer will be diagnosed with early stage disease when the prognosis is excellent as postmenopausal bleeding is an early warning sign that leads women to seek medical advice. Postmenopausal bleeding (PMB) is defined as bleeding • cancer of the uterus, cervix, or vagina (Table 1). that occurs after 1 year of amenorrhea in a woman Endometrial or vaginal atrophy is the most common cause who is not receiving hormone therapy (HT). Women of PMB but more sinister causes of the bleeding such on continuous progesterone and oestrogen hormone as carcinoma must first be ruled out. Patients at risk for therapy can expect to have irregular vaginal bleeding, endometrial cancer are those who are obese, diabetic and/ especially for the first 6 months. This bleeding should or hypertensive, nulliparous, on exogenous oestrogens cease after 1 year. Women on oestrogen and cyclical (including tamoxifen) or those who experience late progesterone should have a regular withdrawal bleeding menopause1 (Table 2).
    [Show full text]